Aurinia Pharmaceuticals (AUPH) Enterprise Value (2016 - 2026)
Aurinia Pharmaceuticals' (AUPH) quarterly Enterprise Value came in at -$378.8 million in Q1 2026, down 21.06% YoY from -$479.8 million in Q1 2025, and up 4.83% on a QoQ basis from -$398.0 million in Q4 2025.
Aurinia Pharmaceuticals (AUPH) Enterprise Value (2016 - 2026) Analysis & Trends
Aurinia Pharmaceuticals (AUPH) has 11 years of Enterprise Value data on file, last reported at -$378.8 million in Q1 2026.
- Quarterly Enterprise Value fell 21.06% year-over-year to -$378.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$378.8 million (down 21.06% YoY) and the FY2025 annual result came in at -$398.0 million, down 11.02% from the prior year.
- Enterprise Value grew to -$378.8 million in Q1 2026, from -$398.0 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$312.9 million in Q1 2025 to a low of -$418.7 million in Q1 2022.
- A 5-year average of -$358.3 million and a median of -$351.8 million in 2025 frame the typical range for Enterprise Value.
- The widest YoY moves for Enterprise Value: up 16.45% in 2022, down 31.51% in 2022.
- Tracing AUPH's Enterprise Value over 5 years: stood at -$389.4 million in 2022, then rose by 9.99% to -$350.5 million in 2023, then fell by 2.28% to -$358.5 million in 2024, then dropped by 11.02% to -$398.0 million in 2025, then increased by 4.83% to -$378.8 million in 2026.
- The last three Enterprise Value figures came in at -$378.8 million (Q1 2026), -$398.0 million (Q4 2025), and -$351.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Aurinia Pharmaceuticals | 2.06 Bn | 1.61 Bn | 76.67 Mn | -443.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -443.12 Mn |
| Mar 31, 2026 | -378.78 Mn |
| Dec 31, 2025 | -398.00 Mn |
| Sep 30, 2025 | -351.81 Mn |
| Jun 30, 2025 | -315.13 Mn |
| Mar 31, 2025 | -312.90 Mn |
| Dec 31, 2024 | -358.48 Mn |
| Sep 30, 2024 | -348.75 Mn |
| Jun 30, 2024 | -330.48 Mn |
| Mar 31, 2024 | -319.91 Mn |
| Dec 31, 2023 | -350.49 Mn |
| Sep 30, 2023 | -337.90 Mn |
| Jun 30, 2023 | -350.71 Mn |
| Mar 31, 2023 | -361.53 Mn |
| Dec 31, 2022 | -389.39 Mn |
| Sep 30, 2022 | -376.64 Mn |
| Jun 30, 2022 | -391.74 Mn |
| Mar 31, 2022 | -418.74 Mn |
| Dec 31, 2021 | -466.08 Mn |
| Sep 30, 2021 | -286.40 Mn |